Cargando…
Care of the Hepatology Patient in the COVID-19 Era
BACKGROUND AND PURPOSE OF REVIEW: The COVID-19 pandemic has resulted in over 800,000 deaths worldwide and resulted in fundamental changes in practice in nearly every aspect of medicine. The majority of symptomatic patients experience liver-associated enzyme (LAE) elevations which appear to be correl...
Autores principales: | Driggers, Kathryn E., Sadowski, Brett W., Shagla, Eva, Kwok, Ryan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970972/ https://www.ncbi.nlm.nih.gov/pubmed/35382426 http://dx.doi.org/10.1007/s11901-021-00581-x |
Ejemplares similares
-
Application of a Mechanistic Model to Evaluate Putative Mechanisms of Tolvaptan Drug-Induced Liver Injury and Identify Patient Susceptibility Factors
por: Woodhead, Jeffrey L., et al.
Publicado: (2017) -
Editor Profiles: Guest Editors of Special Column on Drug- and Chemical-Induced Liver Injury
Publicado: (2021) -
Genetic Factors Influencing Drug-Induced Liver Injury: Do They Have a Role in Prevention and Diagnosis?
por: Clare, Kathleen E., et al.
Publicado: (2017) -
Azathioprine hypersensitivity syndrome in anti-myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Greite, Robert, et al.
Publicado: (2018) -
Pembrolizumab-related renal toxicities: diagnosis first, treatment later
por: Sprangers, Ben
Publicado: (2018)